We are live on ! Find out more
MDXG icon

MiMedx Group

150 hedge funds and large institutions have $290M invested in MiMedx Group in 2022 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 42 increasing their positions, 44 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

160% more call options, than puts

Call options by funds: $1.17M | Put options by funds: $449K

1.48% more ownership

Funds ownership: 53.31%54.79% (+1.5%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

5% less repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 44

1% less funds holding

Funds holding: 152150 (-2)

11% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 18

19% less capital invested

Capital invested by funds: $360M → $290M (-$69.7M)

Holders
150
Holders Change
-2
Holders Change %
-1.32%
% of All Funds
2.37%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
16
Increased
42
Reduced
44
Closed
18
Calls
$1.17M
Puts
$449K
Net Calls
+$718K
Net Calls Change
-$994K
Name Holding Trade Value Shares
Change
Change in
Stake
EWM
1
Essex Woodlands Management
Texas
$110M +$191K +38,961 +0.2%
BlackRock
2
BlackRock
New York
$34.3M +$31.3K +6,402 +0.1%
Vanguard Group
3
Vanguard Group
Pennsylvania
$21.4M +$245K +50,182 +1%
State Street
4
State Street
Massachusetts
$20.8M +$1.22M +250,334 +6%
RB
5
Richmond Brothers
Michigan
$12M -$193K -39,392 -2%
Federated Hermes
6
Federated Hermes
Pennsylvania
$8.1M +$8.13M +1,662,278 +2,944%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$7.75M -$195K -39,806 -2%
Northern Trust
8
Northern Trust
Illinois
$4.64M -$229K -46,758 -5%
N
9
Nuveen
North Carolina
$4.03M +$879K +179,785 +27%
BMO
10
Beck Mack & Oliver
New York
$3.55M +$2.67M +545,507 +262%
Charles Schwab
11
Charles Schwab
California
$3.53M +$80K +16,348 +2%
PCM
12
Parsons Capital Management
Rhode Island
$3.27M -$41.6K -8,500 -1%
D.E. Shaw & Co
13
D.E. Shaw & Co
New York
$2.68M +$553K +113,044 +25%
AWM
14
Axxcess Wealth Management
California
$2.66M
Jacobs Levy Equity Management
15
Jacobs Levy Equity Management
New Jersey
$2.2M +$592K +121,082 +35%
AW
16
Apricus Wealth
South Carolina
$2.01M
Bank of New York Mellon
17
Bank of New York Mellon
New York
$1.86M -$28K -5,717 -1%
NC
18
NovaPoint Capital
Georgia
$1.81M -$46.5K -9,503 -2%
Fisher Asset Management
19
Fisher Asset Management
Washington
$1.75M +$649K +132,631 +55%
Citadel Advisors
20
Citadel Advisors
Florida
$1.67M +$406K +83,073 +31%
DGI
21
Disciplined Growth Investors
Minnesota
$1.56M +$57K +11,648 +4%
Royal Bank of Canada
22
Royal Bank of Canada
Ontario, Canada
$1.49M -$464K -94,963 -23%
Renaissance Technologies
23
Renaissance Technologies
New York
$1.47M +$656K +134,085 +75%
Bank of America
24
Bank of America
North Carolina
$1.41M -$497K -101,608 -25%
Morgan Stanley
25
Morgan Stanley
New York
$1.29M +$592K +121,140 +79%

MDXG Hedge Fund Activity: Q1 2022 in Review

150 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in MiMedx Group (MDXG) for Q1 2022, worth a combined $290M — down 19% from $360M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of MDXG and 16 opened new positions — a net loss of 2 holders — while 44 trimmed existing stakes and 42 added.

The largest buyer was Federated Hermes, adding an estimated $8.13M. The largest seller was Brown Advisory, cutting an estimated $2.44M.

  • 150 institutional investors held MiMedx Group (MDXG) as of Q1 2022, down from 152 in Q4 2021.
  • Funds reported $290M of MiMedx Group stock for Q1 2022, down 19% quarter-over-quarter.
  • 16 funds opened new MiMedx Group positions in Q1 2022 and 18 closed out, a net change of -2 holders.
  • The largest MiMedx Group buyer in Q1 2022 was Federated Hermes, an estimated $8.13M added.
  • The largest MiMedx Group seller in Q1 2022 was Brown Advisory, an estimated $2.44M sold.

Based on aggregated 13F filings for Q1 2022.